The TeaM (hrpeutic ammaplasty) study: Protocol for a prospective multi-centre cohort study to evaluate the practice and outcomes of therapeutic mammaplasty.

International journal of surgery protocols 2016 Vol.1() p. 3-10

Baker E, Kim B, Rattay T, Williams K, Ives C, Remoundos D, Holcombe C, Gardiner MD, Jain A, Sutton R, Achuthan R, Turton P, Fairbrother P, Brock L, Aggarwal S, Basu N, Murphy J, Trickey A, Macmillan RD, Potter S

관련 도메인

Abstract

[INTRODUCTION] Wide local excision and adjuvant radiotherapy is the standard of care for early breast cancer. For large tumours, however, mastectomy is frequently recommended as conventional breast-conserving techniques often result in poor cosmetic outcomes. Therapeutic mammaplasty (TM) may extend the boundaries of breast-conserving surgery by combining breast reduction and mastopexy techniques with tumour excision, preserving a natural breast shape and avoiding the need for mastectomy. The prevalence of this operative option among surgeons in the UK and its success rate are unknown. The TeaM study is a multicentre prospective study that aims to investigate the practice and outcomes of TM.

[METHODS AND ANALYSIS] Breast centres performing TM will be invited to participate through the research collaborative network and the professional associations. All patients undergoing TM between September 2016 and March 2017 will be included. Demographic, operative, oncological and complication data within 30-days of surgery will be collected. The primary outcome will be unplanned re-operation for complications. Secondary outcomes will include unplanned readmission, re-excision rates and time to adjuvant therapy. Prospective data on 500 patients from 50 centres are anticipated. Exploratory analyses will identify predictors for complications and inform the design of a definitive study.

[ETHICS AND DISSEMINATION] Research ethics approval is not required for this study. This has been confirmed by the on-line Health Research Authority decision tool. This study will provide novel information regarding the practice and outcomes of TM in the UK. This will inform decision-making for patients and surgeons and inform future research. Dissemination of the study protocol will be via the Mammary Fold Academic and Research Collaborative, the Reconstructive Surgery Trials Network and the professional associations, the Association of Breast Surgery and British Association of Plastic, Reconstructive and Aesthetic Surgeons. Results will be presented at relevant surgical conferences and published in peer-reviewed journals.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 7
시술 mammaplasty 유방성형술 dict 2
시술 breast reduction 유방성형술 dict 1
시술 mastopexy 유방성형술 dict 1
해부 mammary 유방 dict 1
약물 [INTRODUCTION] Wide scispacy 1
질환 breast cancer C0006142
Malignant neoplasm of breast
scispacy 1
질환 tumour C0027651
Neoplasms
scispacy 1
질환 tumours scispacy 1
기타 TeaM scispacy 1
기타 patients scispacy 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문